[DISCLOSURE]Isu Abxis (086890) said July 4 that it has signed a medicine supply contract worth 30.1 billion won (US$26.2 million) with Iran’s Fara Teb Ayeen to export Abcertin, a drug for Gaucher’s disease.


hnpark@heraldcorp.com